Device
Nasal High Flow Oxygen
Nasal High Flow Oxygen is a medical device with 4 clinical trials. Historical success rate of 66.7%.
Total Trials
4
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
66.7%
Based on 2 completed trials
Completion Rate
67%(2/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(25%)
Phase Distribution
Ph not_applicable
3
75%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
50.0%
2 of 4 finished
Non-Completion Rate
50.0%
2 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(2)
Terminated(2)
Detailed Status
Completed2
Terminated1
Withdrawn1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
66.7%
Most Advanced
N/A
Trials by Phase
N/A3 (100.0%)
Trials by Status
terminated125%
completed250%
withdrawn125%
Recent Activity
0 active trials
Showing 4 of 4
completednot_applicable
High Flow Oxygen in Patients Undergoing Surgery Under General Anesthesia
NCT03554863
terminatednot_applicable
High Flow Oxygen in Patients Undergoing Suspension Laryngoscopy Under General Anesthesia
NCT03472118
withdrawn
Feasibility and Safety of Using Nasal High Flow Oxygen Postoperatively to Reduce Respiratory Complications
NCT04272268
completednot_applicable
Pre-oxygenation With High-flow Nasal Cannula in Caesarian Section Under General Anesthesia
NCT04711317
Clinical Trials (4)
Showing 4 of 4 trials
NCT03554863Not Applicable
High Flow Oxygen in Patients Undergoing Surgery Under General Anesthesia
NCT03472118Not Applicable
High Flow Oxygen in Patients Undergoing Suspension Laryngoscopy Under General Anesthesia
NCT04272268
Feasibility and Safety of Using Nasal High Flow Oxygen Postoperatively to Reduce Respiratory Complications
NCT04711317Not Applicable
Pre-oxygenation With High-flow Nasal Cannula in Caesarian Section Under General Anesthesia
All 4 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 4